Paper Details

  1. Home
  2. Paper Details

[Clinical studies of S6472 in otorhinolaryngologic infections].

Author: BabaS, FurutaS, KatsutaK, KinoshitaH, MoriY, NoboruT, OhnoI, OhyamaM, SuzukiK, YamamotoM

English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

S6472, a long-acting preparation of cefaclor, was effective in 65.8% of 114 patients with otorhinolaryngology infections, particularly tonsillitis, with mild side effects.
Paper Details　
Original Abstract of the Article :
A multicenter cooperative clinical trial was carried out on S6472 (a long-acting preparation of cefaclor (CCL)) to evaluate its effectiveness and safety in the treatment of infectious diseases in the field of otorhinolaryngology. The results are as follows: The clinical efficacy of the drug could be...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/4068219

データ提供：米国国立医学図書館（NLM）

S6472: A Long-Acting Cefaclor for Otorhinolaryngologic Infections

This multicenter clinical trial investigates the effectiveness and safety of S6472, a long-acting preparation of cefaclor, in treating infections of the ear, nose, and throat. Think of this research as a caravan embarking on a journey through a diverse landscape, seeking to understand the effectiveness of a particular remedy.

Effective Treatment for Otorhinolaryngologic Infections

The study found that S6472 demonstrated significant clinical efficacy in treating various otorhinolaryngologic infections, including acute suppurative otitis media, acute tonsillitis, and acute exacerbation of chronic tonsillitis. The overall efficacy rate was particularly high in cases of tonsillitis, suggesting that S6472 could be a valuable treatment option for these conditions.

Navigating the Challenges of Infection

This research highlights the importance of having effective treatment options for otorhinolaryngologic infections, which can significantly impact a person's quality of life. S6472, with its proven efficacy and relatively low side effects, could be a valuable tool for managing these infections, much like a trusty camel providing reliable transportation through a challenging terrain.

Dr.Camel's Conclusion

This clinical trial provides valuable information about the efficacy and safety of S6472 in treating various otorhinolaryngologic infections. The study suggests that this long-acting cefaclor preparation could be a valuable treatment option for these conditions, offering relief and a potential path toward recovery. This research represents a step forward in the quest for effective and safe treatments for common ear, nose, and throat infections.

Date :
  1. Date Completed 1986-01-10
  2. Date Revised 2016-11-16
Further Info :

Pubmed ID

4068219

DOI: Digital Object Identifier

4068219

SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.